Company Filing History:
Years Active: 2017
Title: Xu Qian: Innovator in ALK Inhibitors
Introduction
Xu Qian is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for anaplastic lymphoma kinase (ALK). His work is crucial in advancing treatments for various cancers.
Latest Patents
Xu Qian holds a patent for indoloquinolone compounds that act as ALK inhibitors. This patent includes methods of preparation, pharmaceutical compositions, and various uses of these compounds. The innovation represented by this patent is vital for the ongoing research and development of targeted cancer therapies.
Career Highlights
Xu Qian is associated with Jiangsu Ascentage Biomed Development Inc., where he applies his expertise in drug development. His work at this company underscores his commitment to advancing medical science and improving patient outcomes through innovative therapies.
Collaborations
Xu Qian collaborates with esteemed colleagues, including Jianyong Chen and Yunlong Zhou. These partnerships enhance the research and development efforts within the company, fostering an environment of innovation and discovery.
Conclusion
Xu Qian's contributions to the field of pharmaceuticals, particularly through his patent on ALK inhibitors, highlight his role as a key innovator in cancer treatment. His work continues to impact the medical community positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.